Repair Biotechnologies

Repair Biotechnologies, Inc. was founded in 2018 and is headquartered in New York, USA. It is a biotechnology company dedicated to developing novel therapies and innovative drugs for age-related diseases, addressing health issues caused by aging. Repair Biotechnologies has developed the Cholesterol Degradation Platform (CDP), a first-in-class treatment aimed at reversing atherosclerosis, familial hypercholesterolemia, and other conditions where excess or modified cholesterol drives pathology.